| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/17/2001 | US6217861 pneumococcus; use as drug target for drug screening antibiotics |
| 04/17/2001 | US6217858 Pharmaceutical composition for treating hepatitis B virus (HBV) infection |
| 04/17/2001 | US6217847 Non-invasive localization of a light-emitting conjugate in a mammal |
| 04/17/2001 | US6216612 Ultra fine fly ash and a system for collecting the same |
| 04/17/2001 | CA2188284C Group a streptococcal polysaccharide immunogenic compositions and methods |
| 04/17/2001 | CA2163107C Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates |
| 04/17/2001 | CA2129747C Peptide for diagnosing and immunizing against t. cruzi infection |
| 04/17/2001 | CA2087436C Peptides and analogues and mixtures thereof for detecting antibodies to htlv-i and htlv-ii viruses |
| 04/17/2001 | CA2052323C Oligosaccharide conjugate vaccines |
| 04/13/2001 | CA2321260A1 Oral immunology using plant product containing hepatitis surface antigen |
| 04/13/2001 | CA2320741A1 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 04/13/2001 | CA2320518A1 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 04/12/2001 | WO2001025793A2 Diagnosis of coeliac disease using a gliadin epitope |
| 04/12/2001 | WO2001025446A1 Dna encoding prost 07 polypeptide |
| 04/12/2001 | WO2001025445A1 Fibrinolytically active polypeptide |
| 04/12/2001 | WO2001025442A1 Dna polymerase lambda and uses thereof |
| 04/12/2001 | WO2001025440A1 C3 binding polypeptide of streptococcus agalactiae, group b streptococcus |
| 04/12/2001 | WO2001025438A2 Ifn-alpha homologues |
| 04/12/2001 | WO2001025437A2 Growth factor polypeptides and nucleic acids encoding same |
| 04/12/2001 | WO2001025436A2 Endozepine-like polypeptides and polynucleotides encoding same |
| 04/12/2001 | WO2001025434A1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 04/12/2001 | WO2001025433A2 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 04/12/2001 | WO2001025427A1 Shear stress-response dna |
| 04/12/2001 | WO2001025423A1 Splice variant of head trauma induced cytoplasmatic calcium binding protein |
| 04/12/2001 | WO2001025408A1 Isolated dishevelled associated kinases, polynucleotides encoding the kinases, and methods of use thereof |
| 04/12/2001 | WO2001025398A2 Process for inducing functional tolerance to gene transfer products |
| 04/12/2001 | WO2001025273A2 Compositions and methods for wt1 specific immunotherapy |
| 04/12/2001 | WO2001025272A2 Compositions and methods for therapy and diagnosis of prostate cancer |
| 04/12/2001 | WO2001025271A2 Fibroblast growth factor-5 (fgf-5) is a tumor associated t-cell antigen |
| 04/12/2001 | WO2001025269A2 Human g-protein coupled receptor |
| 04/12/2001 | WO2001025254A2 Novel adjuvant comprising a lipopolysaccharide antagonist |
| 04/12/2001 | WO2001025252A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | WO2001025213A2 Pyrrolo imidazole derivatives and their use as medicaments |
| 04/12/2001 | WO2001024842A2 Hybrid matrices and hybrid matrix mixtures |
| 04/12/2001 | WO2001024833A2 In vivo assay for testing the phenotypic stability |
| 04/12/2001 | WO2001024823A1 Cd40 antagonist for treating psoriasis |
| 04/12/2001 | WO2001024822A2 Pharmaceutical composition comprising an antigen |
| 04/12/2001 | WO2001024820A1 Fusion proteins of mycobacterium tuberculosis |
| 04/12/2001 | WO2001024815A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | WO2001024813A1 Use of tgf beta and growth factors in the treatment and prevention of diseases of the intestinal mucosa |
| 04/12/2001 | WO2001024812A1 USE OF TRANSFORMING GROWTH FACTOR β AND GROWTH FACTORS IN THE TREATMENT AND PREVENTION OF DISEASES OF THE INTESTINAL MUCOSA |
| 04/12/2001 | WO2001024811A1 April receptor (bcma) and uses thereof |
| 04/12/2001 | WO2001024810A1 Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions |
| 04/12/2001 | WO2001024773A1 Liposome-entrapped dna oral vaccines |
| 04/12/2001 | WO2001024771A1 Composition and method of cancer antigen immunotherapy |
| 04/12/2001 | WO2001024764A2 Cell targeting compositions and methods of using the same |
| 04/12/2001 | WO2001024763A2 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 04/12/2001 | WO2000077190A3 Induction of vascular endothelial growth factor (vegf) by the serine/threonine protein kinase akt |
| 04/12/2001 | WO2000071157A3 New vaccine formulations - 1 |
| 04/12/2001 | WO2000069454A8 Suppression of endogenous igfbp-2 to inhibit cancer |
| 04/12/2001 | WO2000065063A3 Nucleic acid vaccines against rickettsial diseases and methods of use |
| 04/12/2001 | WO2000064458A3 Method for inducing a donor tolerance in the human body |
| 04/12/2001 | WO2000057907A3 Multivalent dengue virus vaccine |
| 04/12/2001 | WO2000052147A3 Bacterial prolyl peptidases and methods of use |
| 04/12/2001 | WO2000026667A9 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha |
| 04/12/2001 | WO2000000616A9 Marburg virus vaccines |
| 04/12/2001 | WO1999067283A3 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof |
| 04/12/2001 | WO1997004099A3 Papillomaviruses, agents for detecting them and for treating diseases caused by such viruses |
| 04/12/2001 | CA2388487A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | CA2386841A1 Fusion proteins of mycobacterium tuberculosis |
| 04/12/2001 | CA2386795A1 Pyrrolo imidazole derivatives and their use as medicaments |
| 04/12/2001 | CA2386499A1 Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions |
| 04/12/2001 | CA2386383A1 Growth factor polypeptides and nucleic acids encoding same |
| 04/12/2001 | CA2386377A1 Cell targeting compositions and methods of using the same |
| 04/12/2001 | CA2386252A1 Splice variant of head trauma induced cytoplasmatic calcium binding protein |
| 04/12/2001 | CA2386199A1 Endozepine-like polypeptides and polynucleotides encoding same |
| 04/12/2001 | CA2386185A1 Fibrinolytically active polypeptide |
| 04/12/2001 | CA2386089A1 Diagnostic and therapeutic epitope and transgenic plant |
| 04/12/2001 | CA2386024A1 Liposome-entrapped dna oral vaccines |
| 04/12/2001 | CA2385703A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | CA2385528A1 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 04/12/2001 | CA2385127A1 Novel hepatoma-derived growth factor-like proteins, polynulceotides encoding them and methods of use |
| 04/12/2001 | CA2385045A1 Ifn-alpha homologues |
| 04/12/2001 | CA2385032A1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 04/12/2001 | CA2384696A1 Fibroblast growth factor-5 (fgf-5) is a tumor associated t-cell antigen |
| 04/12/2001 | CA2382859A1 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 04/12/2001 | CA2379971A1 Hybrid matrices and hybrid matrix mixtures |
| 04/12/2001 | CA2379462A1 Human g-protein coupled receptor |
| 04/11/2001 | EP1091000A1 An attenuated vaccination and gene-transfer virus, a method to make the virus and a pharmaceutical composition comprising the virus |
| 04/11/2001 | EP1090995A2 Mycoplasma hyopneumoniae antigen MHP3, gene encoding it and uses thereof |
| 04/11/2001 | EP1090994A2 Peptide repeat immunogens |
| 04/11/2001 | EP1090990A1 Human g-protein-coupled receptor |
| 04/11/2001 | EP1090989A1 Human g-protein-coupled receptor |
| 04/11/2001 | EP1090985A1 Feline-derived T-cells |
| 04/11/2001 | EP1090926A1 Human G-protein coupled receptor |
| 04/11/2001 | EP1090925A1 Human G-protein coupled receptor |
| 04/11/2001 | EP1090643A1 Remedies for hypercalcemic crisis |
| 04/11/2001 | EP1090642A2 Vaccines comprising a polysaccharide antigen-carrier protein conjugate and free carrier protein |
| 04/11/2001 | EP1090641A2 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides |
| 04/11/2001 | EP1090122A1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 04/11/2001 | EP1090118A2 Human signal peptide-containing proteins |
| 04/11/2001 | EP1090115A2 Modularly constructed rna molecules having two sequence region types |
| 04/11/2001 | EP1090104A1 Methods of expanding and selecting disease associated t-cells |
| 04/11/2001 | EP1090039A1 Peptide composition as immunogen for the treatment of allergy |
| 04/11/2001 | EP1090038A2 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore |
| 04/11/2001 | EP1090037A1 Divalent antibody fragments |
| 04/11/2001 | EP1090033A1 Particles of hcv envelope proteins: use for vaccination |
| 04/11/2001 | EP1089766A2 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 04/11/2001 | EP1089759A1 Synthetic peptide vaccines for foot-and-mouth disease |
| 04/11/2001 | EP1089758A1 Mucosal targeting immunisation |